{"attribute_content":[],"type":"Disease","alternate_names":["F11 deficiency","PTA deficiency","Plasma thromboplastin antecedent deficiency","Rosenthal syndrome"],"name":"Hereditary factor XI deficiency disease","alternate_symbols":[],"medgen_id":"C0015523","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012897\"}","{\"db\":\"OMIM\",\"id\":\"612416\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"329\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hereditary+factor+XI+deficiency+disease/8518\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"49762007\",\"ref_field\":\"name\"}"],"id":"1269","keywords":[]}
{"attribute_content":[],"type":"Disease","alternate_names":["Butterfly dystrophy of retinal pigment epithelium","Butterfly-shaped pigment dystrophy of the fovea","Macular dystrophy, butterfly-shaped pigmentary","Patterned dystrophy of retinal pigment epithelium"],"symbol":"MDPT1","alternate_symbols":[],"medgen_id":"C4551999","xrefs":["{\"db\":\"OMIM\",\"id\":\"169150\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"99001\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Patterned+dystrophy+of+retinal+pigment+epithelium/5630\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Patterned dystrophy of retinal pigment epithelium\"}","{\"db\":\"OMIM\",\"id\":\"169150\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5742","keywords":[]}
{"attribute_content":[],"type":"Disease","alternate_names":["VITAMIN D DEPENDENCY, TYPE 1"],"symbol":"VDD1","name":"Vitamin D-dependent rickets, type 1","alternate_symbols":[],"medgen_id":"C0268689","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009924\"}","{\"db\":\"Orphanet\",\"id\":\"289157\"}","{\"db\":\"OMIM\",\"id\":\"264700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"VITAMIN D DEPENDENCY, TYPE 1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Vitamin+D-dependent+rickets%2C+type+1/9453\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"67049004\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"264700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4492","keywords":[]}
{"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301534\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1360\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"3060328\",\"@Source\":\"pmc\"}}]}","attribute_content":[],"type":"Disease","public_definition":"PAX6-related aniridia occurs either as an isolated ocular abnormality or as part of the Wilms tumor-aniridia-genital anomalies-retardation (WAGR) syndrome. Aniridia is a pan ocular disorder affecting the cornea, iris, intraocular pressure (resulting in glaucoma), lens (cataract and lens subluxation), fovea (foveal hypoplasia), and optic nerve (optic nerve coloboma and hypoplasia). Individuals with aniridia characteristically show nystagmus and impaired visual acuity (usually 20/100 - 20/200); however, milder forms of aniridia with subtle iris architecture changes, good vision, and normal foveal structure do occur. Other ocular involvement may include strabismus and occasionally microphthalmia. Although the severity of aniridia can vary between and within families, little variability is usually observed in the two eyes of an affected individual. WAGR syndrome. The risk for Wilms tumor is 42.5%-77%; of those who develop Wilms tumor, 90% do so by age four years and 98% by age seven years. Genital anomalies in males can include cryptorchidism and hypospadias (sometimes resulting in ambiguous genitalia), urethral strictures, ureteric abnormalities, and gonadoblastoma. While females typically have normal external genitalia, they may have uterine abnormalities and streak ovaries. Intellectual disability (defined as IQ \u003c74) is observed in 70%; behavioral abnormalities include attention deficit hyperactivity disorder (ADHD), autism spectrum disorder, anxiety, depression, and obsessive-compulsive disorder. Other individuals with WAGR syndrome can have normal intellect without behavioral problems.","alternate_names":["11p deletion syndrome","11p partial monosomy syndrome","CHROMOSOME 11p13 DELETION SYNDROME","Chromosome 11p deletion syndrome","WAGR Complex","WAGR syndrome","Wilms Tumor-Aniridia-Gonadoblastoma-Mental Retardation syndrome"],"symbol":"WAGR","name":"Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome","alternate_symbols":[],"medgen_id":"C0206115","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008681\"}","{\"db\":\"OMIM\",\"id\":\"194072\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"893\"}","{\"db\":\"Genetic Alliance\",\"id\":\"11p+partial+monosomy+syndrome/7605\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"11p partial monosomy syndrome\"}","{\"db\":\"SNOMED CT\",\"id\":\"4135001\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"11p partial monosomy syndrome\"}","{\"db\":\"OMIM\",\"id\":\"194072\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHROMOSOME 11p13 DELETION SYNDROME\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008681\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"WAGR syndrome\"}","{\"db\":\"Orphanet\",\"id\":\"893\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"WAGR syndrome\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1360\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"194072\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"4509","keywords":[]}
{"attribute_content":[],"type":"Disease","alternate_names":["Insulin-dependent diabetes mellitus","Juvenile diabetes mellitus","Type I diabetes","Type I diabetes mellitus"],"symbol":"IDDM","name":"Diabetes mellitus type 1","alternate_symbols":[],"medgen_id":"C0011854","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0005147\"}","{\"db\":\"OMIM\",\"id\":\"222100\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Insulin-dependent diabetes mellitus\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Juvenile diabetes mellitus\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Type I diabetes\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Type I diabetes mellitus\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Diabetes+mellitus+type+1/8214\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"46635009\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"222100\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1089","keywords":[]}
{"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301402\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1223\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EFNS/MDS-ES, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23279440\",\"@Source\":\"PubMed\"}}]}","attribute_content":[],"type":"Disease","alternate_names":[],"symbol":"PD","name":"Parkinson disease","alternate_symbols":[],"medgen_id":"C0030567","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0005180\"}","{\"db\":\"MeSH\",\"id\":\"D010300\"}","{\"db\":\"OMIM\",\"id\":\"PS168600\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"319705\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Parkinson+Disease/5603\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS168600\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"49049000\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"168600\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"33364","keywords":[]}
{"attribute_content":[],"type":"Disease","alternate_names":["Ovarian epithelial cancer","Ovarian epithelial carcinoma"],"symbol":"EOC","name":"OVARIAN CANCER, EPITHELIAL, SOMATIC","alternate_symbols":[],"medgen_id":"C0677886","xrefs":["{\"db\":\"Genetic Alliance\",\"id\":\"Ovarian+epithelial+cancer/5509\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ovarian epithelial cancer\"}","{\"db\":\"OMIM\",\"id\":\"171834.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"171834.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"171834.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}"],"id":"6319","keywords":[]}
{"attribute_content":[],"type":"Disease","alternate_names":["Anterior segment mesenchymal dysgenesis","Anterior segment ocular dysgenesis"],"symbol":"ASGD1","name":"Anterior segment dysgenesis 1","alternate_symbols":["ASMD","ASOD"],"medgen_id":"C4551992","xrefs":["{\"db\":\"OMIM\",\"id\":\"107250\",\"type\":\"MIM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Anterior+Segment+Mesenchymal+Dysgenesis/513\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anterior segment mesenchymal dysgenesis\"}","{\"db\":\"OMIM\",\"id\":\"107250\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ASMD\"}","{\"db\":\"OMIM\",\"id\":\"107250\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ASOD\"}","{\"db\":\"OMIM\",\"id\":\"107250\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"264","keywords":[]}
{"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301509\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1334\",\"@Source\":\"BookShelf\"}]}}","attribute_content":[],"type":"Disease","public_definition":"Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., \u003c4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.","alternate_names":["HYPOGONADOTROPIC HYPOGONADISM 7 WITH ANOSMIA","HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA"],"symbol":"HH7","name":"Hypogonadotropic hypogonadism 7 with or without anosmia","alternate_symbols":["CHH","nIHH"],"medgen_id":"C0342384","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008192\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008213\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007794\"}","{\"db\":\"OMIM\",\"id\":\"146110\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"432\"}","{\"db\":\"OMIM\",\"id\":\"138850.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 7 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"138850.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"138850.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"138850.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"138850.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"138850.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"138850.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"138850.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"138850.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"138850.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"138850.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"138850.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"138850.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"138850.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1334\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"146110\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2268","keywords":[]}
{"attribute_content":[],"type":"Disease","alternate_names":["Cystic hygroma of the neck"],"name":"Cystic hygroma","alternate_symbols":[],"medgen_id":"C0206620","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000476\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000476\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cystic hygroma of the neck\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000476\",\"ref_field\":\"name\"}"],"id":"21673","keywords":[]}
{"attribute_content":[],"type":"Finding","alternate_names":["Blockage of the rear opening of the nasal cavity","Obstruction of the rear opening of the nasal cavity"],"name":"Choanal atresia","alternate_symbols":[],"medgen_id":"C0008297","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000416\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000453\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004503\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000453\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Blockage of the rear opening of the nasal cavity\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000453\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Obstruction of the rear opening of the nasal cavity\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000453\",\"ref_field\":\"name\"}"],"id":"17129","keywords":[]}
{"attribute_content":[],"type":"Disease","alternate_names":["Dominantly inherited keratitis"],"name":"Keratitis, hereditary","alternate_symbols":[],"medgen_id":"C1835698","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007848\"}","{\"db\":\"OMIM\",\"id\":\"148190\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2334\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Keratitis%2C+hereditary/3971\",\"ref_field\":\"name\"}"],"id":"2510","keywords":[]}
{"attribute_content":[],"type":"Disease","public_definition":"P450scc deficiency is a rare disorder that can present as acute adrenal insufficiency in infancy or childhood. ACTH and plasma renin activity are grossly elevated and adrenal steroids are inappropriately low or absent; the 46,XY patients have female external genitalia, sometimes with clitoromegaly. The phenotypic spectrum ranges from prematurity, complete underandrogenization, and severe early-onset adrenal failure to term birth with clitoromegaly and later-onset adrenal failure (summary by Kim et al., 2008).\r\nAlthough hormonal and phenotypic features can resemble those of congenital lipoid adrenal hyperplasia (lipoid CAH; 201710), no patient with P450scc deficiency has been described with the massive adrenal enlargement typical of lipoid CAH (summary by Sahakitrungruang et al., 2011).","alternate_names":["P450scc DEFICIENCY"],"name":"Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete","alternate_symbols":[],"medgen_id":"C3151055","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0013400\"}","{\"db\":\"OMIM\",\"id\":\"613743\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"168558\"}","{\"db\":\"OMIM\",\"id\":\"613743\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"P450scc DEFICIENCY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Adrenal+insufficiency%2C+congenital%2C+with+46%2CXY+sex+reversal%2C+partial+or+complete/7637\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613743\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}"],"id":"15740","keywords":[]}
{"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301691\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1518\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"CDC, 2012\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"22475884\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"25473725\",\"@Source\":\"PubMed\"},{\"$\":\"NBK258640\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACMG ACT Sheets, 2001\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"American College of Medical Genetics ACT SHEETs, Newborn Screening ACT Sheets and Confirmatory Algorithms\"},\"URL\":{\"$\":\"https://www.ncbi.nlm.nih.gov/books/NBK55827\"}}]}","attribute_content":[],"type":"Disease","public_definition":"The term \"galactosemia\" refers to disorders of galactose metabolism that include classic galactosemia, clinical variant galactosemia, and biochemical variant galactosemia. This GeneReview focuses on: Classic galactosemia, which can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage, bleeding, and E coli sepsis in untreated infants. If a lactose-restricted diet is provided during the first ten days of life, the neonatal signs usually quickly resolve and the complications of liver failure, sepsis, and neonatal death are prevented; however, despite adequate treatment from an early age, children with classic galactosemia remain at increased risk for developmental delays, speech problems (termed childhood apraxia of speech and dysarthria), and abnormalities of motor function. Almost all females with classic galactosemia manifest premature ovarian insufficiency (POI). Clinical variant galactosemia, which can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage including cirrhosis, and bleeding in untreated infants. This is exemplified by the disease that occurs in African Americans and native Africans in South Africa. Persons with clinical variant galactosemia may be missed with newborn screening (NBS) as the hypergalactosemia is not as marked as in classic galactosemia and breath testing is normal. If a lactose-restricted diet is provided during the first ten days of life, the severe acute neonatal complications are usually prevented. African Americans with clinical variant galactosemia and adequate early treatment do not appear to be at risk for long-term complications including POI.","alternate_names":["GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE DEFICIENCY","GALACTOSEMIA I","GALT deficiency","Galactose-1-phosphate uridyltransferase deficiency","Galactosemia, classic","Transferase Deficiency Galactosemia"],"symbol":"GALAC1","name":"Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase","alternate_symbols":[],"medgen_id":"C0268151","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009258\"}","{\"db\":\"OMIM\",\"id\":\"230400\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"352\"}","{\"db\":\"Orphanet\",\"id\":\"79239\"}","{\"db\":\"OMIM\",\"id\":\"230400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"230400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSEMIA I\"}","{\"db\":\"OMIM\",\"id\":\"606999.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSEMIA I\"}","{\"db\":\"OMIM\",\"id\":\"606999.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSEMIA I\"}","{\"db\":\"OMIM\",\"id\":\"606999.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSEMIA I\"}","{\"db\":\"OMIM\",\"id\":\"606999.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSEMIA I\"}","{\"db\":\"OMIM\",\"id\":\"606999.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSEMIA I\"}","{\"db\":\"OMIM\",\"id\":\"606999.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSEMIA I\"}","{\"db\":\"OMIM\",\"id\":\"606999.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSEMIA I\"}","{\"db\":\"OMIM\",\"id\":\"606999.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSEMIA I\"}","{\"db\":\"OMIM\",\"id\":\"606999.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSEMIA I\"}","{\"db\":\"OMIM\",\"id\":\"606999.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSEMIA I\"}","{\"db\":\"OMIM\",\"id\":\"606999.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSEMIA I\"}","{\"db\":\"OMIM\",\"id\":\"606999.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSEMIA I\"}","{\"db\":\"OMIM\",\"id\":\"606999.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSEMIA I\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Deficiency+of+UTP-hexose-1-phosphate+uridylyltransferase/8206\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"124354006\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1518\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"230400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5173","keywords":[]}
{"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301378\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1199\",\"@Source\":\"BookShelf\"}]}}","attribute_content":[],"type":"Disease","public_definition":"CHMP2B frontotemporal dementia (CHMP2B-FTD) has been described in a single family from Denmark, in one individual with familial FTD from Belgium, and in one individual with FTD and no family history. It typically starts between ages 46 and 65 years with subtle personality changes and slowly progressive behavioral changes, dysexecutive syndrome, dyscalculia, and language disturbances. Disinhibition or loss of initiative is the most common presenting symptom. The disease progresses over a few years into profound dementia with extrapyramidal symptoms and mutism. Several individuals have developed an asymmetric akinetic rigid syndrome with arm and gait dystonia and pyramidal signs that may be related to treatment with neuroleptic drugs. Symptoms and disease course are highly variable. Disease duration may be as short as three years or longer than 20 years.","alternate_names":["CHMP2B-Related Frontotemporal Dementia","DEMENTIA, FAMILIAL NONSPECIFIC"],"symbol":"FTD3","name":"Frontotemporal Dementia, Chromosome 3-Linked","alternate_symbols":["DEM","DMT1"],"medgen_id":"C1833296","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010936\"}","{\"db\":\"OMIM\",\"id\":\"600795\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"275864\"}","{\"db\":\"Orphanet\",\"id\":\"282\"}","{\"db\":\"OMIM\",\"id\":\"600795\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DEMENTIA, FAMILIAL NONSPECIFIC\"}","{\"db\":\"OMIM\",\"id\":\"600795\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"DEM\"}","{\"db\":\"OMIM\",\"id\":\"600795\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"DMT1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"CHMP2B-Related+Frontotemporal+Dementia/7968\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1199\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"600795\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1899","keywords":[]}
{"attribute_content":[],"type":"Finding","alternate_names":[],"name":"Subependymal giant-cell astrocytoma","alternate_symbols":[],"medgen_id":"C0205768","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009718\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009718\",\"ref_field\":\"name\"}"],"id":"27709","keywords":[]}
{"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301435\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1258\",\"@Source\":\"BookShelf\"}]}}","attribute_content":[],"type":"Disease","public_definition":"Childhood ataxia with central nervous system hypomyelination / vanishing white matter (CACH/VWM) is characterized by ataxia, spasticity, and variable optic atrophy. The phenotypic range includes a prenatal/congenital form, a subacute infantile form (onset age \u003c1 year), an early childhood-onset form (onset age 1 to \u003c4 years), a late childhood-/juvenile-onset form (onset age 4 to \u003c18 years), and an adult-onset form (onset =18 years). The prenatal/congenital form is characterized by severe encephalopathy. In the later-onset forms initial motor and intellectual development is normal or mildly delayed, followed by neurologic deterioration with a chronic progressive or subacute course. While in childhood-onset forms motor deterioration dominates, in adult-onset forms cognitive decline and personality changes dominate. Chronic progressive decline can be exacerbated by rapid deterioration during febrile illnesses or following head trauma or major surgical procedures, or by acute and extreme fright.","alternate_names":["CACH syndrome","CACH/VWM syndrome","CHILDHOOD ATAXIA WITH CENTRAL NERVOUS SYSTEM HYPOMYELINIZATION","Childhood ataxia with diffuse central nervous system hypomyelination","Cree leukoencehalopathy","LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER, ADULT-ONSET","Myelinosis centralis diffusa"],"symbol":"VWM","name":"Leukoencephalopathy with vanishing white matter","alternate_symbols":["CACH","CLE"],"medgen_id":"C1858991","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011380\"}","{\"db\":\"OMIM\",\"id\":\"603896\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"135\"}","{\"db\":\"Orphanet\",\"id\":\"99853\"}","{\"db\":\"OMIM\",\"id\":\"603896\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHILDHOOD ATAXIA WITH CENTRAL NERVOUS SYSTEM HYPOMYELINIZATION\"}","{\"db\":\"OMIM\",\"id\":\"603945.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER, ADULT-ONSET\"}","{\"db\":\"OMIM\",\"id\":\"603945.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER, ADULT-ONSET\"}","{\"db\":\"OMIM\",\"id\":\"603945.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER, ADULT-ONSET\"}","{\"db\":\"OMIM\",\"id\":\"606273.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER, ADULT-ONSET\"}","{\"db\":\"OMIM\",\"id\":\"606454.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER, ADULT-ONSET\"}","{\"db\":\"OMIM\",\"id\":\"603896\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CACH\"}","{\"db\":\"Genetic Alliance\",\"id\":\"CACH+Syndrome/1012\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1258\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"603896\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2596","keywords":[]}
{"attribute_content":[],"type":"Disease","alternate_names":["SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES"],"symbol":"SBIDDS","name":"Short stature, brachydactyly, intellectual developmental disability, and seizures","alternate_symbols":[],"medgen_id":"C4310689","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0014944\"}","{\"db\":\"OMIM\",\"id\":\"617157\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"464288\"}","{\"db\":\"OMIM\",\"id\":\"610087.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES\"}","{\"db\":\"OMIM\",\"id\":\"610087.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES\"}","{\"db\":\"OMIM\",\"id\":\"610087.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES\"}","{\"db\":\"OMIM\",\"id\":\"610087.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES\"}","{\"db\":\"OMIM\",\"id\":\"610087.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES\"}","{\"db\":\"OMIM\",\"id\":\"610087.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES\"}","{\"db\":\"OMIM\",\"id\":\"617157\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES\"}","{\"db\":\"OMIM\",\"id\":\"617157\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"36195","keywords":[]}
{"attribute_content":[],"type":"Disease","alternate_names":["Pulmonary AVM","Pulmonary arteriovenous fistula","Pulmonary av malformation"],"symbol":"PAVM","name":"Pulmonary arteriovenous malformation","alternate_symbols":[],"medgen_id":"C1857690","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002114\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006537\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006548\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006548\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pulmonary av malformation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006548\",\"ref_field\":\"name\"}"],"id":"25670","keywords":[]}
{"attribute_content":[],"type":"Disease","alternate_names":["Groenouw type II corneal dystrophy","Macular corneal dystrophy Type I","Macular dystrophy, corneal type 1"],"symbol":"MCD","name":"Macular corneal dystrophy","alternate_symbols":["MCDC1"],"medgen_id":"C1636149","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009020\"}","{\"db\":\"OMIM\",\"id\":\"217800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"98969\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Macular+dystrophy%2C+corneal+type+1/4406\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Macular corneal dystrophy Type I\"}","{\"db\":\"SNOMED CT\",\"id\":\"418054005\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Macular corneal dystrophy Type I\"}","{\"db\":\"OMIM\",\"id\":\"217800\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MCDC1\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009020\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"217800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2719","keywords":[]}
{"attribute_content":[],"type":"Disease","alternate_names":["Hodgkin disease","Hodgkin's lymphoma"],"symbol":"CHL","name":"Hodgkin lymphoma","alternate_symbols":[],"medgen_id":"C0019829","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012189\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"236000\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"391\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012189\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hodgkin disease\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012189\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hodgkin's lymphoma\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hodgkin+lymphoma/3444\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012189\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"236000\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"5259","keywords":[]}
{"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301390\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1211\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EGAPP, 2009\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"2743612\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ASCRS, 2001\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"11598466\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15604628\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"AMA/NCHPEG, 2012\",\"@Type\":\"Suggested Reading\",\"URL\":{\"$\":\"http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf\"}},{\"@Abbrev\":\"MSTF, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25070057\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24493721\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"CAPS, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3585492\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"MSTF, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25003300\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO/ESMO, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25452455\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24310308\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Mork et al., 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25711197\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Dutch SCG, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23535968\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACG, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25645574\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Mallorca group, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23408351\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]},{\"@Abbrev\":\"SGO, 2014\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"Society of Gynecologic Oncology (SGO) Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer\"},\"URL\":{\"$\":\"https://www.sgo.org/clinical-practice/guidelines/screening-for-lynch-syndrome-in-endometrial-cancer\"}}]}","attribute_content":[],"type":"Disease","public_definition":"Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, stomach, ovary, small bowel, hepatobiliary tract, urinary tract, brain, and skin. In individuals with Lynch syndrome the following lifetime risks for cancer are seen: CRC: 52%-82% (mean age at diagnosis 44-61 years). Endometrial cancer in females: 25%-60% (mean age at diagnosis 48-62 years). Gastric cancer: 6%-13% (mean age at diagnosis 56 years). Ovarian cancer: 4%-12% (mean age at diagnosis 42.5 years; ~30% are diagnosed \u003c age 40 years). The risk for other Lynch syndrome-related cancers is lower, though substantially increased over general population rates.","alternate_names":["Familial nonpolyposis colon cancer"],"disease_mechanism":"loss of function","disease_mechanism_id":"273","name":"Lynch syndrome","alternate_symbols":[],"medgen_id":"C4552100","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0005835\"}","{\"db\":\"OMIM\",\"id\":\"PS120435\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"144\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000316595\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000321105\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000322202\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000325623\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000332519\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512403\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512828\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515534\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515774\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515821\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000518997\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000518999\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519150\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519254\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520030\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520080\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520392\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520394\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520865\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520867\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520868\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520869\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520870\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520871\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520872\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522224\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522225\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522278\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522559\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527981\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527983\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527984\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528529\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528534\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528914\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528915\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528930\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529017\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530028\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530120\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530202\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551450\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551459\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551461\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551463\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551464\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552183\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552184\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552245\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552440\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558503\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558908\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561860\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562151\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568362\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568365\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569958\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570011\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000591173\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"GeneTests\",\"id\":\"2622\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hereditary+Non-Polyposis+Colorectal+Cancer+%28HNPCC%29/3371\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1211\",\"ref_field\":\"public_definition\"}"],"id":"14688","keywords":[]}
{"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301677\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1504\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"USPSTF, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"2267416\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21915151\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24385074\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2014\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"3918542\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"Camp et al., 2014\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"24667081\",\"@Source\":\"PubMed\"}}]}","attribute_content":[],"type":"Disease","public_definition":"Phenylalanine hydroxylase (PAH) deficiency results in intolerance to the dietary intake of the essential amino acid phenylalanine and produces a spectrum of disorders. The risk of adverse outcome varies based on the degree of PAH deficiency. Without effective therapy, most individuals with severe PAH deficiency, known as classic PKU, develop profound and irreversible intellectual disability. Affected individuals on an unrestricted diet who have phenylalanine levels above normal but below 1,200 Âµmol/L (20 mg/dL) are at much lower risk for impaired cognitive development in the absence of treatment.","alternate_names":["Classic phenylketonuria","Folling disease","Oligophrenia phenylpyruvica","Phenylketonurias"],"disease_mechanism":"loss of function","symbol":"PKU","disease_mechanism_id":"273","name":"Phenylketonuria","alternate_symbols":[],"medgen_id":"C0751434","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009861\"}","{\"db\":\"OMIM\",\"id\":\"261600\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"716\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000260641\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000330994\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000505064\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000505124\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000506557\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507953\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522527\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000560957\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Phenylketonuria/5714\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"154735006\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1504\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"261600\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3795","keywords":[]}
{"content":"{\"Citation\":[{\"@Abbrev\":\"AHRQ, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"NBK248310\",\"@Source\":\"BookShelf\"}},{\"@Abbrev\":\"HRS/EHRA/APHRS, 2013\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"23994779\",\"@Source\":\"PubMed\"}}]}","attribute_content":[],"type":"Disease","alternate_names":[],"disease_mechanism":"loss of function","symbol":"LQTS","mode_of_inheritance":"Various modes of inheritance","disease_mechanism_id":"273","name":"Long QT syndrome","alternate_symbols":["LQT"],"medgen_id":"C0023976","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0002442\"}","{\"db\":\"MeSH\",\"id\":\"D008133\"}","{\"db\":\"OMIM\",\"id\":\"PS192500\",\"type\":\"Phenotypic series\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501111\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511116\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515873\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519089\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520063\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520446\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520456\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520458\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520478\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522197\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522200\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000523361\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000525920\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528497\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528500\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528536\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552174\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552322\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000555634\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558315\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000559512\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000591169\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Long+QT+Syndrome/4296\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS192500\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"9651007\",\"ref_field\":\"name\"}"],"id":"16506","keywords":[]}
{"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301621\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1448\",\"@Source\":\"BookShelf\"}]}}","attribute_content":[],"type":"Disease","public_definition":"Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term \"ZSD\" is now used to refer to all individuals with a PEX gene defect regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and other long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss); neurologic involvement (ataxia, polyneuropathy, and leukodystrophy); liver dysfunction; adrenal insufficiency; and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.","alternate_names":["ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL","INFANTILE PHYTANIC ACID STORAGE DISEASE","PEROXISOME BIOGENESIS DISORDER (NALD/IRD)","PEROXISOME BIOGENESIS DISORDER (NEONATAL ADRENOLEUKODYSTROPHY/INFANTILE REFSUM DISEASE)","Peroxisome biogenesis disorders","Zellweger spectrum disorders","Zellweger syndrome spectrum"],"disease_mechanism":"loss of function","symbol":"PBD, ZSS","disease_mechanism_id":"273","name":"Peroxisome biogenesis disorders, Zellweger syndrome spectrum","alternate_symbols":["PBDS","ZS"],"medgen_id":"C1832200","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0019234\"}","{\"db\":\"Orphanet\",\"id\":\"79189\"}","{\"db\":\"OMIM\",\"id\":\"601539\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL\"}","{\"db\":\"OMIM\",\"id\":\"601539\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INFANTILE PHYTANIC ACID STORAGE DISEASE\"}","{\"db\":\"OMIM\",\"id\":\"601539\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PEROXISOME BIOGENESIS DISORDER (NALD/IRD)\"}","{\"db\":\"OMIM\",\"id\":\"601539\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PEROXISOME BIOGENESIS DISORDER (NEONATAL ADRENOLEUKODYSTROPHY/INFANTILE REFSUM DISEASE)\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500811\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PBDS\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500811\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ZS\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000004880\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000028499\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000028503\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000070507\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000070509\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000318883\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000318886\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000318975\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500811\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501466\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501472\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501473\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501474\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501625\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501626\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501628\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501629\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501630\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501631\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501632\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501633\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501634\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501635\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501644\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501647\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520399\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000525961\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Peroxisome+biogenesis+disorders/5684\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1448\",\"ref_field\":\"public_definition\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1448\",\"ref_field\":\"symbol\"}"],"id":"5752","keywords":[]}
{"attribute_content":[],"type":"Disease","public_definition":"Lynch syndrome, often called hereditary nonpolyposis colorectal cancer (HNPCC), is an inherited disorder that increases the risk of many types of cancer, particularly cancers of the colon (large intestine) and rectum, which are collectively referred to as colorectal cancer. People with Lynch syndrome also have an increased risk of cancers of the stomach, small intestine, liver, gallbladder ducts, urinary tract, brain, and skin. Additionally, women with this disorder have a high risk of cancer of the ovaries and lining of the uterus (endometrial cancer). Women with Lynch syndrome have a higher overall risk of developing cancer than men with the condition because of these cancers of the female reproductive system. Individuals with Lynch syndrome typically develop cancer in their forties or fifties.People with Lynch syndrome may occasionally have noncancerous (benign) growths in the colon, called colon polyps. In individuals with this disorder, colon polyps occur at a younger age but not in greater numbers than they do in the general population.","alternate_names":["Colorectal cancer, hereditary nonpolyposis"],"disease_mechanism":"loss of function","symbol":"HNPCC","disease_mechanism_id":"273","name":"Hereditary nonpolyposis colon cancer","alternate_symbols":[],"medgen_id":"C1333990","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0018630\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"lynch-syndrome\",\"ref_field\":\"public_definition\"}"],"id":"53477","keywords":[]}
{"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301519\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1345\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ASCRS, 2001\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"11598466\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15604628\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21368914\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO/ESMO, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25452455\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24310308\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACG, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25645574\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]}]}","attribute_content":[],"type":"Disease","public_definition":"APC-associated polyposis conditions include: familial adenomatous polyposis (FAP), attenuated FAP, and gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). FAP is a colon cancer predisposition syndrome in which hundreds to thousands of adenomatous colonic polyps develop, beginning, on average, at age 16 years (range 7-36 years). By age 35 years, 95% of individuals with FAP have polyps; without colectomy, colon cancer is inevitable. The mean age of colon cancer diagnosis in untreated individuals is 39 years (range 34-43 years). Extracolonic manifestations are variably present and include: polyps of the gastric fundus and duodenum, osteomas, dental anomalies, congenital hypertrophy of the retinal pigment epithelium (CHRPE), soft tissue tumors, desmoid tumors, and associated cancers. Attenuated FAP is characterized by multiple colonic polyps (average of 30), more proximally located polyps, and a diagnosis of colon cancer at a later age than in FAP. Certain extracolonic manifestations, such as gastric and duodenal polyps or cancers, are variably present in attenuated FAP; risk management may be substantially different between FAP and attenuated FAP. GAPPS is characterized by gastric fundic gland polyposis, increased risk of gastric cancer, and limited colonic involvement in most individuals reported.","alternate_names":["APC-Associated Polyposis Conditions","FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED","POLYPOSIS, ADENOMATOUS INTESTINAL"],"disease_mechanism":"loss of function","symbol":"FAP1","disease_mechanism_id":"273","name":"Familial adenomatous polyposis 1","alternate_symbols":[],"medgen_id":"C2713442","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0021056\"}","{\"db\":\"OMIM\",\"id\":\"175100\",\"type\":\"MIM\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1345\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"APC-Associated Polyposis Conditions\"}","{\"db\":\"OMIM\",\"id\":\"611731.0021\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0028\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0034\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0035\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0036\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0038\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0042\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0043\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0049\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"175100\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"POLYPOSIS, ADENOMATOUS INTESTINAL\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000172265\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000321103\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000330056\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500894\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501393\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501394\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501794\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508954\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512300\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512645\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515534\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515899\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520047\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520069\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520077\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520394\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520865\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520868\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520869\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520870\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520872\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521915\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522559\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527982\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527984\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528912\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529017\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530028\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530118\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530120\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530202\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552245\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552290\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552303\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558907\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570011\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000591173\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1345\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"175100\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"15929","keywords":[]}
{"content":"{\"Citation\":[{\"@Abbrev\":\"EGAPP, 2009\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"2743612\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"AMA/NCHPEG, 2012\",\"@Type\":\"Suggested Reading\",\"URL\":{\"$\":\"http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf\"}}]}","attribute_content":[],"type":"Disease","alternate_names":["COLON CANCER","Familial colorectal cancer"],"disease_mechanism":"loss of function","symbol":"CRC","disease_mechanism_id":"273","name":"COLORECTAL CANCER","alternate_symbols":[],"medgen_id":"CN280943","xrefs":["{\"db\":\"OMIM\",\"id\":\"114500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"COLON CANCER\"}","{\"db\":\"OMIM\",\"id\":\"191170.0021\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"COLON CANCER\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Familial+Colorectal+Cancer/2734\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Familial colorectal cancer\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000321103\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000330058\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000333054\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501399\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501400\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501401\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501402\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501424\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508787\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508788\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508789\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508790\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508791\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508792\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508793\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508794\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508795\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508796\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508797\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508798\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508803\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509789\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510423\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512828\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515534\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515774\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519254\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519256\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519258\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519260\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519489\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519490\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520069\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520080\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520394\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522383\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522559\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527981\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527982\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527983\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527984\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528534\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528654\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530028\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530120\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530202\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552183\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552245\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552303\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558503\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562230\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569958\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570011\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000591173\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"OMIM\",\"id\":\"191170.0038\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"516030.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"516030.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"516030.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"986","keywords":[]}
{"attribute_content":[],"type":"Disease","public_definition":"The peroxisomal biogenesis disorder (PBD) Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).\r\nFor a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.\r\nIndividuals with PBDs of complementation group 4 (CG4, equivalent to CG6 and CGC) have mutations in the PEX6 gene. For information on the history of PBD complementation groups, see 214100.","alternate_names":["Zellweger syndrome spectrum (PEX6-related)"],"disease_mechanism":"loss of function","symbol":"PBD4A","disease_mechanism_id":"273","name":"Peroxisome biogenesis disorder 4a (zellweger)","alternate_symbols":[],"medgen_id":"C3553936","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0013930\"}","{\"db\":\"OMIM\",\"id\":\"614862\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"912\"}","{\"db\":\"OMIM\",\"id\":\"614862\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614862\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"17430","keywords":[]}
{"content":"{\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"3009617\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301469\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1292\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"HFSA, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20610207\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2002\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"12735292\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Eng et al., 2006\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"16980809\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Salviati et al, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"2869001\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"EuroGentest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21934708\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"AHA/ASA, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25355838\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23860966\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ESC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25173338\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]}]}","attribute_content":["{\"Attribute\":{\"$\":\"loss of function\",\"@Type\":\"disease mechanism\",\"@integerValue\":\"273\"},\"XRef\":[{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000505068\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000507480\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000507942\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000522527\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000568367\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000246735\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000260631\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520063\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520447\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528528\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000552214\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000556520\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000558532\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000514924\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520414\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528516\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000551442\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000325415\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000512526\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528276\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528500\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528536\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000556501\"}]}"],"type":"Disease","public_definition":"Fabry disease results from deficient activity of the enzyme alpha-galactosidase A (a-Gal A) and progressive lysosomal deposition of globotriaosylceramide (GL-3) in cells throughout the body. The classic form, occurring in males with less than 1% a-Gal A enzyme activity, usually has its onset in childhood or adolescence with periodic crises of severe pain in the extremities (acroparesthesia), the appearance of vascular cutaneous lesions (angiokeratomas), sweating abnormalities (anhidrosis, hypohidrosis, and rarely hyperhidrosis), characteristic corneal and lenticular opacities, and proteinuria. Gradual deterioration of renal function to end-stage renal disease (ESRD) usually occurs in men in the third to fifth decade. In middle age, most males successfully treated for ESRD develop cardiac and/or cerebrovascular disease, a major cause of morbidity and mortality. Heterozygous females typically have milder symptoms at a later age of onset than males. Rarely, they may be relatively asymptomatic throughout a normal life span or may have symptoms as severe as those observed in males with the classic phenotype. In contrast, males with greater than 1% a-Gal A activity may have: (1) a cardiac variant phenotype that usually presents in the sixth to eighth decade with left ventricular hypertrophy, cardiomyopathy and arrhythmia, and proteinuria, but without ESRD; or (2) a renal variant phenotype, associated with ESRD but without the skin lesions or pain; or (3) cerebrovascular disease presenting as stroke or transient ischemic attack.","alternate_names":["Alpha-galactosidase A deficiency","Anderson-Fabry disease","Angiokeratoma corporis diffusum","Angiokeratoma, diffuse","Ceramide trihexosidase deficiency","Ceramide trihexosidosis","Fabry syndrome","Fabry's disease","GLA deficiency","Hereditary dystopic lipidosis"],"disease_mechanism":"Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.","name":"Fabry disease","alternate_symbols":[],"medgen_id":"C0002986","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010526\"}","{\"db\":\"OMIM\",\"id\":\"301500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"324\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Angiokeratoma corporis diffusum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry syndrome\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Fabry+Disease/2690\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry's disease\"}","{\"db\":\"SNOMED CT\",\"id\":\"16652001\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry's disease\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500007\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6400\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"fabry-disease\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1292\",\"ref_field\":\"public_definition\"}"],"id":"1790","keywords":[],"gard_id":"6400"}
{"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301713\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1544\",\"@Source\":\"BookShelf\"}]}}","attribute_content":[],"type":"Disease","public_definition":"X-linked chondrodysplasia punctata 1 (CDPX1), a congenital disorder of bone and cartilage development, is caused by a deficiency of the Golgi enzyme arylsulfatase E (ARSE). It is characterized by chondrodysplasia punctata (stippled epiphyses), brachytelephalangy (shortening of the distal phalanges), and nasomaxillary hypoplasia. Although most affected males have minimal morbidity and skeletal findings that improve by adulthood, some have significant medical problems including respiratory compromise, cervical spine stenosis and instability, mixed conductive and sensorineural hearing loss, and intellectual disability.","alternate_names":["Arylsulfatase E deficiency","Chondrodysplasia punctata 1, X-linked recessive","Chondrodysplasia punctata, brachytelephalangic"],"symbol":"CDPX1","name":"X-linked chondrodysplasia punctata 1","alternate_symbols":["CPXR"],"medgen_id":"C1844853","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010555\"}","{\"db\":\"OMIM\",\"id\":\"302950\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"79345\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Chondrodysplasia+Punctata+1%2C+X-Linked+Recessive/1367\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Chondrodysplasia punctata 1, X-linked recessive\"}","{\"db\":\"OMIM\",\"id\":\"302950\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CPXR\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1296\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010555\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1544\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"302950\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1431","keywords":[],"gard_id":"1296"}
{"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301509\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1334\",\"@Source\":\"BookShelf\"}]}}","attribute_content":[],"type":"Disease","public_definition":"Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., \u003c4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.","alternate_names":["FGF8-Related Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency","HYPOGONADOTROPIC HYPOGONADISM 6 WITH ANOSMIA","HYPOGONADOTROPIC HYPOGONADISM 6 WITHOUT ANOSMIA","Kallmann syndrome 6"],"symbol":"HH6","name":"Hypogonadotropic hypogonadism 6 with or without anosmia","alternate_symbols":["KAL6"],"medgen_id":"C3552574","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012988\"}","{\"db\":\"OMIM\",\"id\":\"612702\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"478\"}","{\"db\":\"OMIM\",\"id\":\"600483.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 6 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"600483.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 6 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"600483.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 6 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"600483.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 6 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"600483.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 6 WITHOUT ANOSMIA\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Kallmann+syndrome+6/8705\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Kallmann syndrome 6\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10774\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012988\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1334\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"612702\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1882","keywords":[],"gard_id":"10774"}
{"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301321\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1142\",\"@Source\":\"BookShelf\"}]}}","attribute_content":[],"type":"Disease","public_definition":"Progressive myoclonic epilepsy type 1(EPM1) is a neurodegenerative disorder characterized by onset from age six to 15 years, stimulus-sensitive myoclonus, and tonic-clonic epileptic seizures. Some years after the onset, ataxia, incoordination, intentional tremor, and dysarthria develop. Individuals with EPM1 are cognitively mostly within the normal range, but show emotional lability and depression. The epileptic seizures are usually well controlled by antiseizure medications, but the myoclonic jerks are progressive, action activated, and treatment resistant, and can be severely disabling.","alternate_names":["EPILEPSY, PROGRESSIVE MYOCLONIC, 1A","Epilepsy, progressive myoclonic type 1","Epilepsy, progressive myoclonus 1","Myoclonic epilepsy of Unverricht and Lundborg","Myoclonus progressive epilepsy of Unverricht and Lundborg","Progressive myoclonus epilepsy baltic myoclonic epilepsy","Unverricht-Lundborg Disease"],"name":"Unverricht-Lundborg syndrome","alternate_symbols":["EPM1","EPM1A","PME","ULD"],"medgen_id":"C0751785","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009698\"}","{\"db\":\"OMIM\",\"id\":\"254800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"308\"}","{\"db\":\"OMIM\",\"id\":\"254800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EPILEPSY, PROGRESSIVE MYOCLONIC, 1A\"}","{\"db\":\"OMIM\",\"id\":\"254800\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EPM1\"}","{\"db\":\"OMIM\",\"id\":\"254800\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EPM1A\"}","{\"db\":\"OMIM\",\"id\":\"254800\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PME\"}","{\"db\":\"OMIM\",\"id\":\"254800\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ULD\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3876\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Myoclonus+progressive+epilepsy+of+Unverricht+and+Lundborg/5038\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"230423006\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1142\",\"ref_field\":\"public_definition\"}"],"id":"5584","keywords":[],"gard_id":"3876"}
{"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"23946963\",\"@Source\":\"PubMed\"},{\"$\":\"NBK153722\",\"@Source\":\"BookShelf\"}]}}","attribute_content":[],"type":"Disease","public_definition":"PIK3CA-associated segmental overgrowth includes disorders of brain (e.g., MCAP [megalencephaly-capillary malformation] syndrome, hemimegalencephaly); and segmental body overgrowth (e.g., CLOVES [congenital lipomatous asymmetric overgrowth of the trunk, lymphatic, capillary, venous, and combined-type vascular malformations, epidermal nevi, skeletal and spinal anomalies] syndrome, fibroadipose hyperplasia [FH]). Heterozygous (usually somatic mosaic) pathogenic variants of PIK3CA are causative. MCAP syndrome is characterized by the major findings of (1) megalencephaly (MEG) or hemimegalencephaly (HMEG) associated with neurologic findings of hypotonia, seizures, and mild to severe intellectual disability; and (2) cutaneous capillary malformations with focal or generalized somatic overgrowth. Additional findings can include digital anomalies (syndactyly, polydactyly), cortical malformations â most distinctively polymicrogyria (PMG); and variable connective tissue dysplasia. CLOVES (or CLOVE) syndrome and fibroadipose hyperplasia (FH) may be associated with (1) MEG or HMEG; and (2) patchy segmental overgrowth associated with skeletal anomalies, lipomatosis, vascular malformations, and epidermal nevi.","alternate_names":["MACROCEPHALY-CAPILLARY MALFORMATION","MEGALENCEPHALY-CAPILLARY MALFORMATION SYNDROME","MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME, SOMATIC","Macrocephaly cutis marmorata telangiectatica congenita","Macrocephaly-capillary malformation syndrome (M-CM, MCAP)","Megalencephaly cutis marmorata telangiectatica congenita","Megalencephaly-Capillary Malformation (MCAP) Syndrome","Megalocephaly cutis marmorata telangiectatica congenita","PIK3CA-Related Segmental Overgrowth"],"symbol":"MCAP","name":"Megalencephaly-capillary malformation-polymicrogyria syndrome","alternate_symbols":["M-CMTC","MCM"],"medgen_id":"C1865285","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011240\"}","{\"db\":\"OMIM\",\"id\":\"602501\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"60040\"}","{\"db\":\"OMIM\",\"id\":\"602501\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MACROCEPHALY-CAPILLARY MALFORMATION\"}","{\"db\":\"OMIM\",\"id\":\"602501\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MEGALENCEPHALY-CAPILLARY MALFORMATION SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"171834.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME, SOMATIC\"}","{\"db\":\"OMIM\",\"id\":\"171834.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME, SOMATIC\"}","{\"db\":\"OMIM\",\"id\":\"171834.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME, SOMATIC\"}","{\"db\":\"OMIM\",\"id\":\"171834.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME, SOMATIC\"}","{\"db\":\"OMIM\",\"id\":\"171834.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME, SOMATIC\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Macrocephaly-Capillary+Malformation/4560\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Megalencephaly cutis marmorata telangiectatica congenita\"}","{\"db\":\"OMIM\",\"id\":\"602501\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MCM\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6950\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011240\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK153722\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"602501\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2584","keywords":[],"gard_id":"6950"}
{"attribute_content":[],"type":"Disease","alternate_names":["TFP deficiency","Trifunctional protein deficiency","Trifunctional protein deficiency type 1","Trifunctional protein deficiency with myopathy and neuropathy"],"symbol":"MTPD","name":"Mitochondrial trifunctional protein deficiency","alternate_symbols":["TFP"],"medgen_id":"C1969443","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012172\"}","{\"db\":\"OMIM\",\"id\":\"609015\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"746\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3684\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mitochondrial+trifunctional+protein+deficiency/4834\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"237999008\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609015\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"9419","keywords":[],"gard_id":"3684"}
{"content":"{\"Citation\":{\"@Abbrev\":\"NCCN, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"22138009\",\"@Source\":\"PubMed\"}}}","attribute_content":[],"type":"Disease","alternate_names":[],"name":"Glioma","alternate_symbols":[],"medgen_id":"C0017638","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009733\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0021042\"}","{\"db\":\"MeSH\",\"id\":\"D005910\"}","{\"db\":\"OMIM\",\"id\":\"PS137800\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"182067\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6513\",\"ref_field\":\"gard_id\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009733\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS137800\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"393564001\",\"ref_field\":\"name\"}"],"id":"18479","keywords":[],"gard_id":"6513"}
{"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301691\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1518\",\"@Source\":\"BookShelf\"}]}}","attribute_content":[],"type":"Disease","public_definition":"The term \"galactosemia\" refers to disorders of galactose metabolism that include classic galactosemia, clinical variant galactosemia, and biochemical variant galactosemia. This GeneReview focuses on: Classic galactosemia, which can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage, bleeding, and E coli sepsis in untreated infants. If a lactose-restricted diet is provided during the first ten days of life, the neonatal signs usually quickly resolve and the complications of liver failure, sepsis, and neonatal death are prevented; however, despite adequate treatment from an early age, children with classic galactosemia remain at increased risk for developmental delays, speech problems (termed childhood apraxia of speech and dysarthria), and abnormalities of motor function. Almost all females with classic galactosemia manifest premature ovarian insufficiency (POI). Clinical variant galactosemia, which can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage including cirrhosis, and bleeding in untreated infants. This is exemplified by the disease that occurs in African Americans and native Africans in South Africa. Persons with clinical variant galactosemia may be missed with newborn screening (NBS) as the hypergalactosemia is not as marked as in classic galactosemia and breath testing is normal. If a lactose-restricted diet is provided during the first ten days of life, the severe acute neonatal complications are usually prevented. African Americans with clinical variant galactosemia and adequate early treatment do not appear to be at risk for long-term complications including POI.","alternate_names":["Galactose intolerance"],"disease_mechanism":"loss of function","disease_mechanism_id":"273","name":"Galactosemia","alternate_symbols":[],"medgen_id":"C0016952","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004919\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0018116\"}","{\"db\":\"Orphanet\",\"id\":\"352\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004919\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Galactose intolerance\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569081\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2424\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Galactosemia/2973\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"190745006\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1518\",\"ref_field\":\"public_definition\"}"],"id":"16954","keywords":[],"gard_id":"2424"}
{"attribute_content":[],"type":"Disease","alternate_names":["Cone-rod dystrophy 3"],"symbol":"CORD3","alternate_symbols":[],"medgen_id":"C1858806","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011395\"}","{\"db\":\"OMIM\",\"id\":\"604116\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1872\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cone-Rod+Dystrophy+3/1769\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cone-rod dystrophy 3\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10653\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"604116\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"831","keywords":[],"gard_id":"10653"}
{"attribute_content":[],"type":"Disease","alternate_names":["FG syndrome 2"],"symbol":"FGS2","alternate_symbols":[],"medgen_id":"C1845902","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010297\"}","{\"db\":\"OMIM\",\"id\":\"300321\",\"type\":\"MIM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"FG+Syndrome+2/2843\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FG syndrome 2\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9923\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"300321\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"1281","keywords":[],"gard_id":"9923"}
{"attribute_content":[],"type":"Disease","alternate_names":["ANTERIOR SEGMENT DYSGENESIS 5"],"symbol":"ASGD5","name":"Irido-corneo-trabecular dysgenesis","alternate_symbols":[],"medgen_id":"C4310809","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000659\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011414\"}","{\"db\":\"OMIM\",\"id\":\"604229\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"708\"}","{\"db\":\"OMIM\",\"id\":\"604229\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANTERIOR SEGMENT DYSGENESIS 5\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7377\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Irido-corneo-trabecular+dysgenesis/8682\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"204153003\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604229\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3486","keywords":[],"gard_id":"7377"}
{"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"22379635\",\"@Source\":\"PubMed\"},{\"$\":\"NBK84399\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"24624459\",\"@Source\":\"PubMed\"},{\"$\":\"NBK190101\",\"@Source\":\"BookShelf\"}]}]}","attribute_content":[],"type":"Disease","public_definition":"PRSS1-related hereditary pancreatitis (HP) is characterized by episodes of acute pancreatitis (AP) and recurrent acute pancreatitis (RAP: \u003e1 episode of AP), with frequent progression to chronic pancreatitis (CP). Manifestations of acute pancreatitis can range from vague abdominal pain lasting one to three days to severe abdominal pain lasting days to weeks and requiring hospitalization.","alternate_names":["Hereditary chronic pancreatitis","PRSS1-Related Hereditary Pancreatitis"],"symbol":"PCTT","name":"Hereditary pancreatitis","alternate_symbols":["CPANC","HP","HPC"],"medgen_id":"C0238339","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008185\"}","{\"db\":\"OMIM\",\"id\":\"167800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"676\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008185\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hereditary chronic pancreatitis\"}","{\"db\":\"Orphanet\",\"id\":\"676\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hereditary chronic pancreatitis\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK84399\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PRSS1-Related Hereditary Pancreatitis\"}","{\"db\":\"OMIM\",\"id\":\"167800\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HP\"}","{\"db\":\"OMIM\",\"id\":\"167800\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HPC\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6632\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hereditary+pancreatitis/3373\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"68072000\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK84399\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"167800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"3261","keywords":[],"gard_id":"6632"}
{"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301509\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1334\",\"@Source\":\"BookShelf\"}]}}","attribute_content":[],"type":"Disease","public_definition":"Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., \u003c4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.","alternate_names":["FGFR1-Related Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency","HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA, SUSCEPTIBILITY TO","HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA","HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO","Kallmann syndrome 2"],"disease_mechanism":"loss of function","symbol":"HH2","disease_mechanism_id":"273","name":"Hypogonadotropic hypogonadism 2 with or without anosmia","alternate_symbols":["KAL2"],"medgen_id":"C1563720","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007844\"}","{\"db\":\"OMIM\",\"id\":\"147950\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"478\"}","{\"db\":\"OMIM\",\"id\":\"136350.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"136350.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"136350.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"136350.0020\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"136350.0023\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"136350.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"136350.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"136350.0024\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"136350.0025\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Kallmann+syndrome+2/3947\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Kallmann syndrome 2\"}","{\"db\":\"OMIM\",\"id\":\"147950\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"KAL2\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508944\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511562\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511608\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511610\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511611\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511612\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511613\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512869\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556729\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556731\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558347\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569425\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3070\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007844\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1334\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"147950\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"2438","keywords":[],"gard_id":"3070"}
{"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301509\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1334\",\"@Source\":\"BookShelf\"}]}}","attribute_content":[],"type":"Disease","public_definition":"Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., \u003c4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.","alternate_names":["ANOSMIC HYPOGONADISM","DYSPLASIA OLFACTOGENITALIS OF DE MORSIER","HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA","HYPOGONADOTROPIC HYPOGONADISM AND ANOSMIA","KAL1-Related Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency","Kallmann syndrome 1","Kallmann syndrome, X-linked","Kallmann syndrome, type 1, X-linked"],"disease_mechanism":"loss of function","symbol":"HH1","disease_mechanism_id":"273","name":"Hypogonadotropic hypogonadism 1 with or without anosmia","alternate_symbols":["HHA","KAL1","KMS"],"medgen_id":"C1563719","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010635\"}","{\"db\":\"OMIM\",\"id\":\"308700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"478\"}","{\"db\":\"OMIM\",\"id\":\"308700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANOSMIC HYPOGONADISM\"}","{\"db\":\"OMIM\",\"id\":\"308700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DYSPLASIA OLFACTOGENITALIS OF DE MORSIER\"}","{\"db\":\"OMIM\",\"id\":\"300836.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"300836.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"300836.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"300836.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"300836.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"300836.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"300836.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"300836.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"300836.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"300836.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"300836.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"300836.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"300836.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"300836.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"308700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM AND ANOSMIA\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Kallmann+syndrome%2C+type+1%2C+X-linked/3949\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Kallmann syndrome 1\"}","{\"db\":\"OMIM\",\"id\":\"308700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HHA\"}","{\"db\":\"OMIM\",\"id\":\"308700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"KAL1\"}","{\"db\":\"OMIM\",\"id\":\"308700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"KMS\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508943\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511585\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512869\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529045\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556729\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556730\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558347\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569425\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3071\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010635\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1334\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"308700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"id":"6234","keywords":[],"gard_id":"3071"}
